Cited by 1,119Heart Failure Treatment and ManagementElectrolyte and hormonal disordersCardiovascular Function and Risk Factors

The use of diuretics in heart failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology

Open access
Mullens, Wilfried, Damman, Kevin, Harjola, Veli-Pekka, Mebazaa, Alexandre, Brunner-La Rocca, Hans-Peter, Martens, Pieter, Testani, Jeffrey M., Tang, W.H. Wilson +7 more·2019·European Journal of Heart Failure

Abstract

The vast majority of acute heart failure episodes are characterized by increasing symptoms and signs of congestion with volume overload. The goal of therapy in those patients is the relief of congestion through achieving a state of euvolaemia, mainly through the use of diuretic therapy. The appropriate use of diuretics however remains challenging, especially when worsening renal function, diuretic resistance and electrolyte disturbances occur. This position paper focuses on the use of diuretics in heart failure with congestion. The manuscript addresses frequently encountered challenges, such as (i) evaluation of congestion and clinical euvolaemia, (ii) assessment of diuretic response/resistance in the treatment of acute heart failure, (iii) an approach towards stepped pharmacologic diuretic strategies, based upon diuretic response, and (iv) management of common electrolyte disturbances. Recommendations are made in line with available guidelines, evidence and expert opinion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.1369

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Device therapies (implantable cardioverter defibrillator, cardiac resynchronization therapy, and CRT with an implantable defibrillator) have similar efficacies and risks in patients with HFrEF with or without diabetes.

    “Device therapies (implantable cardioverter defibrillator [ICD], cardiac resynchronization therapy [CRT], and CRT with an implantable defibrillator [CRT-D]) have similar efficacies and risks in patients with HFrEF with or without diabetes.[522][523][524][525]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 1

  1. © 2018 The Authors European Journal of Heart Failure © 2018 European Society of Cardiology 132.

Cited by

Sorted by citations

Authors
Mullens, W., Damman, K., Harjola, V.-P., Mebazaa, A., Brunner-La Rocca, H.-P., Martens, P., Testani, J. M., Tang, W. H. W., Orso, F., Rossignol, P., Metra, M., Filippatos, G., Seferovic, P. M., Ruschitzka, F., & Coats, A. J.
Affiliations
  • Ziekenhuis Oost Limburg , Genk ,
  • University Medical Center Groningen (NL)
  • University of Helsinki (FI)
  • Inserm (FR)
  • Maastricht University Medical Center , Maastricht ,
  • Ziekenhuis Oost-Limburg (BE)
  • Yale University (US)
  • Cleveland Clinic (US)
  • University of Florence (IT)
  • University of Brescia (IT)
  • National and Kapodistrian University of Athens (GR)
  • University of Belgrade (RS)
  • University Hospital Zurich (CH)
  • IRCCS San Raffaele Roma (IT)
Venue
European Journal of Heart Failure
Published
2019-01-01
Volume
21
Issue
2
Pages
137-155
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2907983377
Cited by
1,119
References
145
Citations by year
2026: 136 · 2025: 156 · 2024: 177 · 2023: 206 · 2022: 145 · 2021: 130 · 2020: 111 · 2019: 56
FWCI
79.82
Type
journal article
Language
en
Open access
Locations
  • European Journal of Heart Failure (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Document Server@UHasselt (UHasselt) (submittedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
  • Zenodo (CERN European Organization for Nuclear Research) (cc-by)
Funders
National Heart, Lung, and Blood Institute (R01HL103931)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Electrolyte and hormonal disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
diuretics, acute heart failure, fluid overload, diuretic resistance, diuretic response, electrolyte imbalance, renal function, fluid status assessment
MeSH terms
Cardiology, Diuretics, Europe, Heart Failure, Humans, Societies, Medical, Stroke Volume, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review